Could a simple test spare thousands of young women from harsh chemo?
NCT ID NCT07106632
Summary
This study aims to see if a genetic test can safely guide treatment decisions for younger women with a common type of early breast cancer. It will compare the standard approach of giving chemotherapy to everyone against a personalized plan where some women receive only hormone therapy. The goal is to reduce harsh side effects and improve quality of life without increasing the risk of the cancer returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HR+ HER2- BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut Gustave Roussy
Villejuif, 94800, France
Conditions
Explore the condition pages connected to this study.